Goodwin Procter Represents F-star Alpha in up to $475 Million Exclusive Purchase Option with Bristol-Myers Squibb

Goodwin attorneys recently advised F-star Alpha Ltd in connection with its exclusive option agreement with Bristol-Myers Squibb. Bristol-Myers Squibb has purchased an exclusive option to acquire F-Star Alpha and thereby gain worldwide rights to FS102, a Human Epidermal growth factor Receptor 2 (HER-2)-targeted therapy. Under the terms of the agreement, Bristol-Myers Squibb will make payments aggregating to $50 million that consist of an option fee for the right to acquire F-star Alpha, payment for certain rights and licenses from F-star Alpha and a clinical milestone payment upon initiation of the Phase 1 trial. Total aggregate consideration may reach $475 million. Additional details regarding the transaction are available in BMS’s press release. More >>

Tags:  Goodwin Procter LLP | Boston

White & Case Represents Freeport LNG in $3.85 Billion Debt Financing

Global law firm White & Case LLP represented Freeport LNG Expansion, L.P. (Freeport LNG) and its subsidiary FLNG Liquefaction, LLC (FLIQ1) in its recently signed $3.85 billion debt financing for the development of the first liquefaction train (Train 1) of Freeport LNG’s multi-train liquefaction and export facility at Quintana Island near Freeport, Texas. More >>

Tags:  White & Case LLP | New York | Washington

Stibbe advises Tornier

Stibbe advises Tornier N.V. on its merger with Wright Medical Group, Inc. in an all stock transaction with a combined equity value of approximately $3.3 billion. More >>

Tags:  Stibbe | Amsterdam

Shearman & Sterling Represents Jaguar Land Rover Automotive on $500 Million Fixed Rate High Yield Bonds Offering

Shearman & Sterling represented Jaguar Land Rover Automotive plc (“Jaguar Land Rover”) on its offering of $500 million fixed rate high yield bonds due 2019. Jaguar Land Rover Automotive plc, an indirectly-owned subsidiary of Indian-owned Tata Motors Limited (India), bought luxury carmakers Jaguar Land Rover Limited and Land Rover in 2008. More >>

Tags:  Shearman & Sterling LLP | London | Washington

Ropes & Gray Represents CRC Health Group in $1.175 Billion Sale to Acadia Healthcare

Ropes & Gray represented CRC Health Group Inc. in its planned $1.175 billion acquisition by Acadia Healthcare announced Oct. 29. CRC is a California-based substance abuse treatment provider operating 120 facilities dedicated to the service of approximately 40,000 patients each day. The deal is scheduled to be completed in the first quarter of 2015. More >>

Tags:  Ropes & Gray LLP | Boston

Milbank Advises on Momentive’s Restructuring

Momentive Performance Materials Inc. (with its subsidiaries “Momentive”) is one of the world’s largest producers of silicones and silicone derivatives, and is a global leader in the development and manufacture of products derived from quartz and specialty ceramics. Milbank represented an ad hoc committee of creditors (the “Ad Hoc Committee”), collectively holding over $400 million of the second lien notes issued by Momentive. The company encountered severe liquidity issues in 1Q 2014 as the continued slowdown of global economic growth and increasing over-capacity in its industry negatively impacted the results of both the silicones and quartz businesses. More >>

Tags:  Milbank LLP | New York